EllieMD announced the debut of a line of Hormone Replacement Therapy (HRT) products. The company described the launch as more than the addition of a new product category, but rather a reflection of the company’s “commitment to pioneering self-health for people struggling to find solutions for their wellness needs.” The HRT line aligns with the company’s strategic structure, which combines telehealth and trusted medical providers with its relationship-driven distribution model.
Designed to serve the 50 million women in the US experiencing symptoms of menopause, 75% of whom do not receive care for their symptoms, the HRT line is expected to serve as a valuable resource for customers and position the company at the forefront of a significant shift in women’s health by offering self-health options.
“Women spent decades paying the price for outdated information,” said Hanieh Sigari, EllieMD Founder & CEO. “Millions were told to fear therapies that, for many, could have meaningfully improved their quality of life and health span, while countless suffered in silence. HRT is more than a product launch for us. It’s a reminder to ask a much bigger question: What other preventative therapies are people missing because science hasn’t caught up with perception? That’s the mission we’ve dedicated EllieMD to. We are building the future of community-powered health by making evidence-based, physician-guided preventative care more accessible, more personalized and available long before disease begins. We’ll continue challenging old thinking, advocating for our communities and fighting to bring better healthcare to everyone.”
